Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
Placental dysfunction is the underlying cause of pregnancy complications such as fetal growth restriction (FGR) and pre-eclampsia. No therapies are available to treat a poorly functioning placenta, primarily due to the risks of adverse side effects in both the mother and the fetus resulting from sys...
Saved in:
Main Authors: | Lewis J. Renshall (Author), Frances Beards (Author), Angelos Evangelinos (Author), Susan L. Greenwood (Author), Paul Brownbill (Author), Adam Stevens (Author), Colin P. Sibley (Author), John D. Aplin (Author), Edward D. Johnstone (Author), Tambet Teesalu (Author), Lynda K. Harris (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MORPHOLOGICAL FEATURES OF PLACENTAS IN PREGNANCIES WITH FETAL GROWTH RESTRICTION SYNDROME
by: N.A. MURATNAZAROVA
Published: (2024) -
DNA methylation of the Rtl1 promoter in the placentas with fetal growth restriction
by: Kazumichi Fujioka, et al.
Published: (2019) -
Differences of Zinc and Copper Levels In Placenta Blood Normal Neonates and Intrauterine Growth Restriction
by: Melda Amalia, et al.
Published: (2018) -
Galectin-1 expression in the serum and placenta of pregnant women with fetal growth restriction and its significance
by: Xiao-Xiao Jin, et al.
Published: (2021) -
Editorial on Special Issue "Precision Delivery of Drugs and Imaging Agents with Peptides"
by: Kaido Kurrikoff, et al.
Published: (2022)